Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients Visa övriga samt affilieringar
2024 (Engelska) Ingår i: Journal of Translational Medicine, E-ISSN 1479-5876, Vol. 22, nr 1, artikel-id 947Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Background: Mounting evidence suggests a significant role of the gut microbiota in the development and progression of colorectal cancer (CRC). In particular, an over-representation of oral pathogens has been linked to CRC. The aim of this study was to further investigate the faecal microbial landscape of CRC patients, with a focus on the oral pathogens Parvimonas micra and Fusobacterium nucleatum.
Methods: In this study, 16S rRNA sequencing was conducted using faecal samples from CRC patients (n = 275) and controls without pathological findings (n = 95).
Results: We discovered a significant difference in microbial composition depending on tumour location and microsatellite instability (MSI) status, with P. micra, F. nucleatum, and Peptostreptococcus stomatis found to be more abundant in patients with MSI tumours. Moreover, P. micra and F. nucleatum were associated with a cluster of CRC-related bacteria including Bacteroides fragilis as well as with other oral pathogens such as P. stomatis and various Porphyromonas species. This cluster was distinctly different in the control group, suggesting its potential linkage with CRC.
Conclusions: Our results suggest a similar distribution of several CRC-associated bacteria within CRC patients, underscoring the importance of considering the concomitant presence of bacterial species in studies investigating the mechanisms of CRC development and progression.
Ort, förlag, år, upplaga, sidor BioMed Central (BMC), 2024. Vol. 22, nr 1, artikel-id 947
Nyckelord [en]
Colorectal cancer, Fusobacterium nucelatum, Intestinal microbiota, Oral pathobionts, Parvimonas micra
Nationell ämneskategori
Mikrobiologi inom det medicinska området
Identifikatorer URN: urn:nbn:se:umu:diva-231532 DOI: 10.1186/s12967-024-05720-8 ISI: 001338945800003 PubMedID: 39420333 Scopus ID: 2-s2.0-85206620492 OAI: oai:DiVA.org:umu-231532 DiVA, id: diva2:1915105
Forskningsfinansiär Cancerfonden Sjöbergstiftelsen Vetenskapsrådet Cancerforskningsfonden i Norrland Umeå universitet Region Västerbotten 2024-11-212024-11-212025-02-24 Bibliografiskt granskad